Hep C Virus - AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery

AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery
[Press Release] Business Wire via Yahoo! Finance - Mar 07 6:00 AM
PORTLAND, Ore.----March 7, 2006--AVI BioPharma, Inc. , today announced that the February issue of Nature Reviews Drug Discovery chose to highlight the company's recent Ebola study results.Save to My Web

Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

Tampa Firm's Medication Has Enormous Potential As Hepatitis Treatment
The Tampa Tribune - Feb 24 7:50 PM
TAMPA - Digestive disease specialist David Heiman has dozens of chronic hepatitis C patients who do not respond to the drugs now available. Their only hope is a transplant before their liver gives out.Save to My Web

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus Session at the BIO CEO & Investor Conference in New York
[Press Release] PR Newswire via Yahoo! Finance - Feb 13 10:26 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, has been selected to participate in the "Breakthroughs in Hepatitis" focus session at the 8th Annual BIO CEO & Investor Conference in New York City, February 14th and 15th.Save to My Web